INVITATION
Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
INVITATION
Servier - Can current treatment strategies for mCRC be further optimized?
INVITATION
Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer
INVITATION
Ipsen - The today and tomorrow of systemic treatment for HCC
INVITATION
Merck KGaA - From complexity to clarity: Optimizing the mCRC continuum of care (Medical)
INVITATION
Incyte Biosciences International Sàrl - Patient centricity in cholangiocarcinoma: A multidisciplinary discussion